11-[2-(2-Phenyl-ethenesulfonylamino)-ethylsulfanyl]-6,11-dihydro-dibenzo[b,e]oxepine-2-carboxylic acid

ID: ALA324364

Chembl Id: CHEMBL324364

PubChem CID: 10480363

Max Phase: Preclinical

Molecular Formula: C25H23NO5S2

Molecular Weight: 481.60

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2

Standard InChI:  InChI=1S/C25H23NO5S2/c27-25(28)19-10-11-23-22(16-19)24(21-9-5-4-8-20(21)17-31-23)32-14-13-26-33(29,30)15-12-18-6-2-1-3-7-18/h1-12,15-16,24,26H,13-14,17H2,(H,27,28)/b15-12+

Standard InChI Key:  QTZKOUSSPHZWGR-NTCAYCPXSA-N

Associated Targets(Human)

TBXA2R Tclin Thromboxane A2 receptor (5717 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TBXAS1 Tchem Thromboxane-A synthase (3355 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Tbxas1 Thromboxane-A synthase (658 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cavia porcellus (23802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 481.60Molecular Weight (Monoisotopic): 481.1018AlogP: 4.69#Rotatable Bonds: 8
Polar Surface Area: 92.70Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 4.31CX Basic pKa: CX LogP: 4.37CX LogD: 1.41
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.45Np Likeness Score: -0.43

References

1. Ohshima E, Takami H, Sato H, Obase H, Miki I, Ishii A, Karasawa A, Kubo K..  (1992)  Non-prostanoid thromboxane A2 receptor antagonists with a dibenzoxepin ring system. 1.,  35  (18): [PMID:1388207] [10.1021/jm00096a016]
2. Ohshima E, Takami H, Sato H, Obase H, Miki I, Ishii A, Karasawa A, Kubo K..  (1992)  Non-prostanoid thromboxane A2 receptor antagonists with a dibenzoxepin ring system. 1.,  35  (18): [PMID:1388207] [10.1021/jm00096a016]
3. Ohshima E, Takami H, Sato H, Obase H, Miki I, Ishii A, Karasawa A, Kubo K..  (1992)  Non-prostanoid thromboxane A2 receptor antagonists with a dibenzoxepin ring system. 1.,  35  (18): [PMID:1388207] [10.1021/jm00096a016]
4. Ohshima E, Takami H, Sato H, Obase H, Miki I, Ishii A, Karasawa A, Kubo K..  (1992)  Non-prostanoid thromboxane A2 receptor antagonists with a dibenzoxepin ring system. 1.,  35  (18): [PMID:1388207] [10.1021/jm00096a016]
5. Ohshima E, Takami H, Sato H, Obase H, Miki I, Ishii A, Karasawa A, Kubo K..  (1992)  Non-prostanoid thromboxane A2 receptor antagonists with a dibenzoxepin ring system. 1.,  35  (18): [PMID:1388207] [10.1021/jm00096a016]
6. Ohshima E, Takami H, Sato H, Obase H, Miki I, Ishii A, Karasawa A, Kubo K..  (1992)  Non-prostanoid thromboxane A2 receptor antagonists with a dibenzoxepin ring system. 1.,  35  (18): [PMID:1388207] [10.1021/jm00096a016]

Source